Meridian Bioscience Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (20)

Latest Posts

About This Stock More About This Stock
4 Lucrative MedTech Stocks To Bet On In 2021 Amid Pandemic
Article By: Zacks Investment Research
Friday, April 2, 2021 6:16 AM EDT
As 2021 progresses, investors can safely put their bets on stocks that have shown excellent prowess amid the pandemic-induced volatility and have solid growth potential.
In this article: HRC, MCK, OMI, VIVO Also: BDX
Read
Bull Of The Day: Meridian Bioscience, Inc.
Article By: Kevin Cook
Monday, March 22, 2021 9:58 AM EDT
Meridian Bioscience is a $1 billion provider of diagnostic test kits for gastrointestinal and respiratory infectious diseases. The company is expected to grow sales by 28.6% this year to $326 million.
In this article: VIVO Also: NVAX, QDEL, HOLX
Read
Meridian Bioscience Checks All The Right Marks
Article By: Tickeron
Wednesday, March 17, 2021 3:30 PM EDT
Meridian Biocience is a life science company that has seen strong earnings and revenue growth, is in an upward trend, and isn't terribly overvalued. There is also a sense of pessimism toward the stock from analysts.
In this article: VIVO
Read
Bull Of The Day: Meridian Bioscience (VIVO)
Article By: Kevin Cook
Friday, January 8, 2021 9:13 AM EDT
Meridian Bioscience is a $900 million provider of diagnostic test kits for gastrointestinal and respiratory infectious diseases. The company is expected to grow sales 18% this year to $300 million.
In this article: VIVO Also: QDEL, HOLX, EDIT, CRSP
Read
Week In Review: Korea's Samsung BioLogics Files For $2.5 Billion IPO
Article By: ChinaBio® Today
Saturday, August 13, 2016 1:13 PM EDT
Samsung BioLogics filed for an IPO on South Korea's main board that will raise between $1.8 and $2.7 billion, valuing the company at $9 billion.
In this article: BMY, CLSN, TECH, VIVO
Read

Latest Tweets for $VIVO

No tweets yet!